Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed M Rehman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 18, 2010
How to manage the left subclavian artery during endovascular stenting of the thoracic aortaSyed M Rehman, Joshua A Vecht, Ryan Perera, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2018
Conventional aortic valve replacement in 2005 elderly patients: a 32-year experienceThierry Langanay, Simon Rouzé, Jacques Tomasi, et al.
Immunotherapy|May 6, 2021
Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig<sup>®</sup> [octanorm])Roger H Kobayashi, Jose Fernando Mandujano, Syed M Rehman, et al.
Structural Heart : the Journal of the Heart Team|January 29, 2024
Bicuspid Aortic Valve Disease: Classifications, Treatments, and Emerging Transcatheter ParadigmsAnkur Kalra, Rajiv Das, Mohammad Alkhalil, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Advances in Therapy|May 9, 2026
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study)Chaim M Roifman, Donald McNeil, William Lumry, et al.
Annals of Vascular Surgery|September 14, 2010
How to manage the left subclavian artery during endovascular stenting for thoracic aortic dissection? An assessment of the evidenceSyed M Rehman, Joshua A Vecht, Ryan Perera, et al.
The Annals of Thoracic Surgery|April 19, 2015
A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass GraftingDavid P Taggart, Yanai Ben Gal, Belinda Lees, et al.
JAMA|November 28, 2018
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical TrialAleena Banerji, Marc A Riedl, Jonathan A Bernstein, et al.
The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 18, 2010
How to manage the left subclavian artery during endovascular stenting of the thoracic aortaSyed M Rehman, Joshua A Vecht, Ryan Perera, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2018
Conventional aortic valve replacement in 2005 elderly patients: a 32-year experienceThierry Langanay, Simon Rouzé, Jacques Tomasi, et al.
Immunotherapy|May 6, 2021
Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig<sup>®</sup> [octanorm])Roger H Kobayashi, Jose Fernando Mandujano, Syed M Rehman, et al.
Structural Heart : the Journal of the Heart Team|January 29, 2024
Bicuspid Aortic Valve Disease: Classifications, Treatments, and Emerging Transcatheter ParadigmsAnkur Kalra, Rajiv Das, Mohammad Alkhalil, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Advances in Therapy|May 9, 2026
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study)Chaim M Roifman, Donald McNeil, William Lumry, et al.
Annals of Vascular Surgery|September 14, 2010
How to manage the left subclavian artery during endovascular stenting for thoracic aortic dissection? An assessment of the evidenceSyed M Rehman, Joshua A Vecht, Ryan Perera, et al.
The Annals of Thoracic Surgery|April 19, 2015
A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass GraftingDavid P Taggart, Yanai Ben Gal, Belinda Lees, et al.
JAMA|November 28, 2018
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical TrialAleena Banerji, Marc A Riedl, Jonathan A Bernstein, et al.
The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.
Pageof 2